glp-1 agonists thyroid cancer receptor agonist use for more than 1 year may increase risk Do GLP-1 Medications Cause Thyroid
Description
& Anderson, P
Melson E, Alexander A, Miras D, Papamargaritis D
Zepbounds commercial rise showed that dual agonism could become the next dominant mechanism in obesity care
Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study
Sustained liraglutide administration for 3 weeks increases urinary sodium excretion independent of changes in ANP or blood pressure in overweight and obese hypertensive patients with type 2 diabetes 22
From a translational standpoint, this complexity has historically been viewed as a liability, particularly when human data appeared inconsistent or mechanistically incomplete (Mera et al., 2016)
